Skip to main content

Christin Melton

Feature
07/19/2011
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data...
07/19/2011
First Report Managed Care
10/14/2011
Elderly patients who receive proton pump inhibitors (PPIs) while using alendronate, an oral bisphosphonate typically prescribed to reduce the risk of osteoporotic fractures, may have poorer response to alendronate. According to a...
Elderly patients who receive proton pump inhibitors (PPIs) while using alendronate, an oral bisphosphonate typically prescribed to reduce the risk of osteoporotic fractures, may have poorer response to alendronate. According to a...
Elderly patients who receive...
10/14/2011
First Report Managed Care
08/23/2011
A Korean study found percutaneous coronary intervention with sirolimus-eluting stents noninferior to coronary artery bypass grafting in patients.
A Korean study found percutaneous coronary intervention with sirolimus-eluting stents noninferior to coronary artery bypass grafting in patients.
A Korean study found...
08/23/2011
First Report Managed Care